Complexed PSA in routine diagnosisOREMEK, G. M; SAPOUTZIS, N; EDEN, F et al.Anticancer research. 2003, Vol 23, Num 2A, pp 975-977, issn 0250-7005, 3 p.Conference Paper

¹¹C-acetate PET imaging of prostate cancer: Detection of recurrent disease at PSA relapse. CommentaryOYAMA, Nobuyuki; MILLER, Tom R; DIMITRAKOPOULOU-STRAUSS, Antonia et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 4, pp 549-558, issn 0161-5505, 10 p.Article

Effects of hepatocyte growth factor on urokinase-type plasminogen activator (uPA) and uPA receptor in DU145 prostate cancer cellsNISHIMURA, Kenji; MATSUMIYA, Kiyomi; MIURA, Hidenobu et al.International journal of andrology (Print). 2003, Vol 26, Num 3, pp 175-179, issn 0105-6263, 5 p.Article

Androgen receptor and prostate cancer invasionBONACCORSI, Lorella; MURATORI, Monica; CARLONI, Vinicio et al.International journal of andrology (Print). 2003, Vol 26, Num 1, pp 21-25, issn 0105-6263, 5 p.Article

Molecular analysis of the androgen receptor in ten prostate cancer specimens obtained before and after androgen ablationLAMB, Dolores J; PUXEDDU, Efisio; MALIK, Nusrat et al.Journal of andrology. 2003, Vol 24, Num 2, pp 215-225, issn 0196-3635, 11 p.Article

Regulation of prostate-specific antigen gene expression by an LH-RH analogue in human prostatic cellsSICA, Gigliola; ZELANO, Giovanni; SETTESOLDI, Daniela et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1283-1287, issn 0250-7005, 5 p.Article

Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migrationLIU, Jun-Wei; SHEN, Jian-Jun; TANZILLO-SWARTS, Angela et al.Oncogene (Basingstoke). 2003, Vol 22, Num 10, pp 1475-1485, issn 0950-9232, 11 p.Article

A zero PSA slope in posttreatment prostate-specific antigen supports cure of patients with long-term follow-up after external beam radiotherapy for localized prostate cancerTAKAMIYA, Robert; WEINBERG, Vivian; YOUNG, C. Dale et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 4, pp 1073-1078, issn 0360-3016, 6 p.Conference Paper

Neoadjuvant doxil chemotherapy prior to androgen ablation plus radiotherapy for high-risk localized prostate cancer: Feasibility and toxicityOH, William K; KAPLAN, Irving D; FEBBO, Philip et al.American journal of clinical oncology. 2003, Vol 26, Num 3, pp 312-316, issn 0277-3732, 5 p.Article

Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinomaROSSER, Charles J; REYES, Adriana O; VAKAR-LOPEZ, Funda et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 1, pp 1-6, issn 0360-3016, 6 p.Article

Definitive radiotherapy of prostate cancer: The possible role of staging lymphadenectomyFOSSA, Sophie D; LILLEBY, Wolfgang; WAEHRE, Hakon et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 1, pp 33-41, issn 0360-3016, 9 p.Article

Dose escalation for localized prostate cancer: Substantial benefit observed with 3D conformal therapySYMON, Zvi; GRIFFITH, Kent A; MCLAUGHLIN, P. William et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 2, pp 384-390, issn 0360-3016, 7 p.Article

Altered localization and activity of the intracellular tyrosine kinase BKR/Sik in prostate tumor cellsDERRY, Jason J; PRINS, Gail S; RAY, Vera et al.Oncogene (Basingstoke). 2003, Vol 22, Num 27, pp 4212-4220, issn 0950-9232, 9 p.Article

Metafectene is superior to lipofectamine in the transfection of G₅α prostate cancer cellsICZKOWSKI, Kenneth A; OMARA-OPYENE, A. Levi; KLÖSEL, Roland et al.Molecular biotechnology. 2004, Vol 28, Num 2, pp 97-103, issn 1073-6085, 7 p.Article

Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancerKUPELIAN, Patrick A; POTTERS, Louis; KHUNTIA, Deepak et al.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 1, pp 25-33, issn 0360-3016, 9 p.Article

Gene expression profiles of 13C- and DIM-treated PC3 Human prostate cancer cells determined by cDNA microarray analysisYIWEI LI; XINGLI LI; SARKAR, Fazlul H et al.The Journal of nutrition. 2003, Vol 133, Num 4, pp 1011-1019, issn 0022-3166, 9 p.Article

High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicityADAMSON, Janet; MORGAN, Elwin A; BEESLEY, Carol et al.Oncogene (Basingstoke). 2003, Vol 22, Num 18, pp 2739-2749, issn 0950-9232, 11 p.Article

Id-1 expression promotes cell survival through activation of NF-κB signalling pathway in prostate cancer cellsLING, Ming-Tat; XIANGHONG WANG; OUYANG, Xue-Song et al.Oncogene (Basingstoke). 2003, Vol 22, Num 29, pp 4498-4508, issn 0950-9232, 11 p.Article

Structure activity relationship studies of natural product chemokine receptor CCR5 antagonist anibamine toward the development of novel anti prostate cancer agentsFENG ZHANG; ARNATT, Christopher K; HANEY, Kendra M et al.European journal of medicinal chemistry. 2012, Vol 55, pp 395-408, issn 0223-5234, 14 p.Article

Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapyZELEFSKY, Michael J; YAMADA, Yoshiya; MARION, Christine et al.International journal of radiation oncology, biology, physics. 2003, Vol 55, Num 4, pp 956-963, issn 0360-3016, 8 p.Article

Use of portal images and BAT ultrasonography to measure setup error and organ motion for prostate IMRT: Implications for treatment marginsLITTLE, Darren J; LEI DONG; LEVY, Lawrence B et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 5, pp 1218-1224, issn 0360-3016, 7 p.Article

What to do for prostate cancer patients with a rising PSA? A survey of australian practiceDUCHESNE, Gillian M; MILLAR, Jeremy L; MORAGA, Vladimir et al.International journal of radiation oncology, biology, physics. 2003, Vol 55, Num 4, pp 986-991, issn 0360-3016, 6 p.Article

Towards integrating functional imaging in the treatment of prostate cancer with radiation: The registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planningMIZOWAKI, Takashi; COHEN, Gil'Ad N; FUNG, Albert Y. C et al.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 5, pp 1558-1564, issn 0360-3016, 7 p.Article

A comparison of CT scan to transrectal ultrasound-measured prostate volume in untreated prostate cancerHOFFELT, S. Christopher; MARSHALL, Lynn M; GARZOTTO, Mark et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 1, pp 29-32, issn 0360-3016, 4 p.Article

Urinary symptom flare following I-125 prostate brachytherapyCESARETTI, Jamie A; STONE, Nelson N; STOCK, Richard G et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 4, pp 1085-1092, issn 0360-3016, 8 p.Conference Paper